August 23, 2017 5:06pm

 

… On what, low volume!

Take it when you can get it … yet the advance/decline line was marginally balanced to the upside (21/18)

 

Today’s upside was based on pure speculation

 

Pre-open indications:  1 hit and 5 miss

 

It’s called premium content for a reason … I define insight  from a real-time perspective discussing equity share pricing, attractiveness and support levels as stock pricing changes by the hour … if not the minute!

Others don’t even come close!

 

I answer one question, in which company should investors commit and keep their money.

 

 

Wednesday’s results have implications to Thursday’s sector activity as a daily report may say little or a lot and it serves as insurance that all indications are being examined and evaluated!

 

Henry’omics:

From the pre-open’s investor’s newsletter, “…watch your corners. Yesterday, the IBB +1.92%, the XBI +2.39%, The XLV +1.21% and the IWM +1.08% were up as the VIX was down -13.95% and sector volume was below even normal … With a “happy” high, a low usually follows.”

  • With so many uncertainties weighing on sector equities due to their being overvalued one day and undervalued the next; I am a bit perplexed that we saw an upward movement today.

In the short-term, they're  VERY vulnerable!

  • Volume is still very low but, driving the pick-up as share pricing jumps and the advance/decline lines are SLIGHTLY balanced to the upside

 

Speculation is running rampart as low volume upticks can quickly become downdrafts!

 

 

The advance/decline line scenario of 43 SCGT & RT covered companies:   

·         The first hour was negative with an A/DL of 15/21 and 6 flats;

·         The mid-day was positive with an A/DL of 23/16 and 4 flat;

·         The close was positive  with an A/DL of 21/18 and 4 flat;

 

 

Pre-open indications: 1 hit and 5 miss

  • Applied Genetic Technologies (AGTC) closed down -$0.05 – miss;
  • Biostage (BSTG) closed up +0.067 – miss;
  • Mesoblast (MESO) closed down -$0.03 – miss;
  • Cellectis SA (CLLS) closed up + $0.10 – miss;
  • Intrexon (XON) closed up +$0.21 – miss;
  • MiMedx (MDXG) was up +$0.44 – hit;

 

 

Regenerative Medicine Earnings Scorecard - Q2/2017 - to date – so far

http://www.regmedinvestors.com/articles/9841

 

Daily analytics:

The Dow on Wednesday marked its longest streak without a gain of at least 1% in more than a decade, according to WSJ Market Data Group.

  • The Dow (-0.40%) hasn't posted a rise of at least 1% since April 25, when it rallied 232 points or 1.1%. Its failure to do so on Wednesday marks the 84th trading day without such an advance, the longest since a 102-session streak ended March 2007.

The Dow closed off 0.4% at 21,812, the S&P 500 indexes SPX, -0.35% was off 0.4% at 2,444, while the NASDAQ closed off 0.3% at 6,278.

 

The CBOE Volatility Index (VIX) widely considered the best gauge of fear in the market, Wednesday traded at 11.91, up +4.93% …

  • Tuesday traded at 11.40, down -13.57% after Monday traded at 13.08, down -7.57% … Friday traded 14.22, down -8.55% after Thursday traded 15.55, up +32.45% while last Wednesday traded at 11.74, down -2.49%

 

Welcome to another day of the sector’s roller coaster …

… The iShares Russell 2000 (IWM) indicated:

·         Wednesday was down -0.18%

·         Tuesday+1.08%

·         Monday -0.04%

·         Friday -0.03%

·         Thursday -1.80%

·         Last Wednesday +0.04%

… The iShares NASDAQ Biotechnology (IBB) indicated:

·         Wednesday was down -0.44%

·         Tuesday +1.92%

·         Monday +0.20%

·         Friday -0.25%

·         Thursday -1.70%

·         Last Wednesday +0.25%

 

 

The count - decliners versus gainers:

……. look at the differences in the spreads as decliners jump and %

·         Wednesday’s decliners ranged from -0.31% <CYTX -$0.001> to -5.13% <RENE.L -$0.10> in 18 equities;

·         Tuesday’s decliners ranged from -0.57% <HSGX -$0.01> to -5.27% <BSTG -$0.0148> in 11 equities;

·         Monday’s decliners ranged from -0.30% <IMUC -$0.001> to -6.75% <NWBO -$0.0135> in 20 equities;

·         Friday’s decliners ranged from -0.13% <OPXA -$0.001> to -13.01% <BSTG -$0.04> in 23 equities;

·         Thursday’s decliners ranged from -0.48% <BCLI> to -9.71% <RGNX> in 30 equities;

·         Last Wednesday’s decliners ranged from -0.31% <BSTG> to -5.36% <SGMO> in 21 equities;

 

Versus

… Look at the percentage’s (%) and spreads …

·         Wednesdays gainers ranged from +0.08% <CLLS +$0.02> to +25.24% <BSTG +$0.067> in 21 equities;

·         Tuesday’s gainers ranged from +0.33% <OSIR +$0.02> to +20.25% <OPXA +$0.16> in 28 equities;

·         Monday’s gainers ranged from +0.22% <BLUE +$0.20> to +5.74% <OPXA +$0.04> in 14 equities;

·         Friday’s gainers ranged from +0.48% <BCLI +$0.02> to +9.89% <NWBO -$0.02> in 17 equities;

·         Thursday’s gainers ranged from +0.23% <QURE> to +14.33% <IMUC> in 9 equities;

·         Last Wednesday’s gainers ranged from +0.05% <BLUE> to +7.44% <IMUC> in 21 equities;

 

 

Some of MY working trend lines or indications:

… The greatest volume to the downside:  IMUC, MDXG, NWBO, ONVO and CYTX

… Upside volume was weighted to:  BSTG, KITE, JUNO, OPXA and XON

… Biggest $ downside:  MDXG, QURE, OSIR, RENE.L and ONVO

… Largest $ upside:  KITE, ONCE, JUNO, BLUE and RGNX

… Flat:  STML, VCEL, ISCO and ATHX

 

 

Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.  All investments are subject to risks. Investors should consider investment objectives.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.